Bahram Valamehr
Chief Development Officer
Other
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Fate Therapeutics Inc (FATE) | Ph.D., MBA President, Chief Executive Officer and Director | $600,000 | $2,248,568 |
| 2024 | Fate Therapeutics Inc (FATE) | Chief Research and Development Officer | $525,000 | $3,584,600 |
| 2023 | Fate Therapeutics Inc (FATE) | Chief Research and Development Officer | $500,000 | $2,986,615 |
| 2022 | Fate Therapeutics Inc (FATE) | Chief Research and Development Officer | $455,000 | $3,157,751 |
| 2021 | Fate Therapeutics Inc (FATE) | Chief Research and Development Officer | $430,000 | $6,477,416 |
| 2019 | Fate Therapeutics Inc (FATE) | Chief Development Officer | $375,000 | $2,818,586 |
| 2018 | Fate Therapeutics Inc (FATE) | Chief Development Officer | $321,865 | $2,577,350 |
Executive changes
-
Appointed President and CEO (and as the Company's principal executive officer, principal financial officer and principal accounting office at Fate Therapeutics Inc (FATE)2025-01-01
- 2025-01-01
Earnings-call appearances
-
Fate Therapeutics Inc Q2 FY2020 Earnings Call2020-08-05
Fate Therapeutics Inc (FATE)